Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Consortium to Study the Genetics of Lead Pollution in India

By Labmedica staff writers
Posted on 09 Feb 2007
Consortium to Study the Genetics of Lead Pollution in India
A consortium has been formed to study how genetics and environmental lead pollution interact to affect the intellectual and behavioral development of children in India.
Research groups from two American universities, Harvard University (Boston, MA, USA) and the University of Michigan (Ann Arbor, USA) are working with the biotechnology company Bioserve (Laurel, MD, USA; and Hyderabad, India) on this three-year study. More...
BioServe, which has state-of-the-art laboratory facilities in India, will undertake DNA purification and genotyping on tissue samples collected from 750 school children in Chennai (formerly Madras), India who have been exposed to lead pollutants.
The goal is to determine how individual genetic makeup may modify the neurobehavioral impact of lead exposure and to relate these findings to how lead exposure affects both visual-spatial-motor skills and aggressive behavior.
"This study represents a cutting edge research collaboration that will gain insights into a global environmental health problem,” said Dr. Howard Hu, professor of environmental medicine at the University of Michigan. "Understanding the interrelationship of environmental hazards, genetics, and health will provide the information that is needed to formulate regulatory policies, prioritize public health controls, and educate the medical community and the public on how best to mitigate particular environmental exposures.”
Rama Modali, chief executive officer of BioServe, said, "We are excited to play an important role in this landmark health study. Our genotyping studies will contribute to the Indian and international biomedical communities' further understanding of the dynamics between lead exposure and chronic diseases, as well as genetic polymorphisms that increase the risk of environmentally induced disease.”



Related Links:
University of Michigan
Harvard University
Bioserve

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.